Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial. (BICS)
Seonaidh Cotton, Graham Devereux*, Hassan Abbas, Andrew Briggs, Karen Campbell, Rekha Chaudhuri, Gourab Choudhury, Dana K Dawson, Anthony De Soyza, Shona Fielding, Simon Gompertz, John Haughney, Chim C Lang, Amanda J Lee, Graeme MacLennan, William MacNee, Kirsty McCormack, Nicola McMeekin, Nicholas L Mills, Alyn MoriceJohn Norrie, Mark C. Petrie, David Price, Philip Short, Jorgen Vestbo, Paul Walker, Jadwiga A Wedzicha, Andrew M. Wilson, Brian J. Lipworth
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial. (BICS)'. Together they form a unique fingerprint.